Biomedical Engineering Reference
In-Depth Information
Eguchi, A. & Dowdy, S. F. (2009) siRNA delivery using peptide transduction domains.
Trends
Pharmacol Sci
, 30, 341-5.
Eguchi, A. & Dowdy, S. F. (2010) Efficient siRNA delivery by novel PTD-DRBD fusion proteins.
Cell Cycle
, 9, 424-5.
Eguchi, A., Meade, B. R., Chang, Y. C., Fredrickson, C. T., Willert, K., Puri, N. & Dowdy, S. F.
(2009) Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA
binding domain fusion protein.
Nat Biotechnol
, 27, 567-71.
El-Sayed, A., Futaki, S. & Harashima, H. (2009) Delivery of macromolecules using arginine-rich
cell-penetrating peptides: ways to overcome endosomal entrapment.
Aaps J
, 11, 13-22.
Elfinger, M., Maucksch, C. & Rudolph, C. (2007) Characterization of lactoferrin as a targeting
ligand for nonviral gene delivery to airway epithelial cells.
Biomaterials
, 28, 3448-55.
Ercan, M. T. & Caglar, M. (2000) Therapeutic radiopharmaceuticals.
Curr Pharm Des
,
6, 1085-121.
Famulok, M., Hartig, J. S. & Mayer, G. (2007) Functional aptamers and aptazymes in biotechnology,
diagnostics, and therapy.
Chem Rev
, 107, 3715-43.
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P. & Langer,
R. (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
Proc
Natl Acad Sci U S A
, 103, 6315-20.
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T. N., Lavan, D. A. & Langer, R. (2004)
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
Cancer Res
, 64, 7668-72.
Ferkol, T., Perales, J. C., Mularo, F. & Hanson, R. W. (1996) Receptor-mediated gene transfer into
macrophages.
Proc Natl Acad Sci U S A
, 93, 101-5.
Ferreira, C. S., Cheung, M. C., Missailidis, S., Bisland, S. & Gariepy, J. (2009) Phototoxic aptamers
selectively enter and kill epithelial cancer cells.
Nucleic Acids Res
, 37, 866-76.
Gabizon, A. A. (2001) Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new
form of chemotherapy.
Cancer Invest
, 19, 424-36.
Gagne, J. F., Desormeaux, A., Perron, S., Tremblay, M. J. & Bergeron, M. G. (2002) Targeted
delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes.
Biochim Biophys
Acta
, 1558, 198-210.
Gao, W., Xiao, Z., Radovic-Moreno, A., Shi, J., Langer, R. & Farokhzad, O. C. (2010) Progress
in siRNA delivery using multifunctional nanoparticles.
Methods Mol Biol
, 629, 53-67.
Goldenberg, D. M. (2002) Targeted therapy of cancer with radiolabeled antibodies.
J Nucl Med
,
43, 693-713.
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S. & Gabizon, A. (2000) Nuclear
delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance
efflux pump.
Clin Cancer Res
, 6, 1949-57.
Greish, K. (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors:
a royal gate for targeted anticancer nanomedicines.
J Drug Target
, 15, 457-64.
Griffin, J. D., Linch, D., Sabbath, K., Larcom, P. & Schlossman, S. F. (1984) A monoclonal anti-
body reactive with normal and leukemic human myeloid progenitor cells.
Leuk Res
,
8, 521-34.
Gullotti, E. & Yeo, Y. (2009) Extracellularly activated nanocarriers: a new paradigm of tumor
targeted drug delivery.
Mol Pharm
, 6, 1041-51.
Gump, J. M. & Dowdy, S. F. (2007) TAT transduction: the molecular mechanism and therapeutic
prospects.
Trends Mol Med
, 13, 443-8.
Gunaseelan, S., Gunaseelan, K., Deshmukh, M., Zhang, X. & Sinko, P. J. (2010) Surface modifi-
cations of nanocarriers for effective intracellular delivery of anti-HIV drugs.
Adv Drug Deliv
Rev
, 62, 518-31.
Gupta, U. & Jain, N. K. (2010) Non-polymeric nano-carriers in HIV/AIDS drug delivery and
targeting.
Adv Drug Deliv Rev
, 62, 478-90.
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K. & Shasha, D. (2002) Impact of tumor hypoxia
and anemia on radiation therapy outcomes.
Oncologist
, 7, 492-508.
Search WWH ::
Custom Search